返回ChemicalBook首页>CAS数据库列表>159989-65-8

159989-65-8

中文名称 甲磺酸奈非那韦
英文名称 Nelfinavir mesylate
CAS 159989-65-8
分子式 C33H49N3O7S2
MDL 编号 MFCD00931436
分子量 663.89
MOL 文件 159989-65-8.mol
更新日期 2024/05/07 11:49:31
159989-65-8 结构式 159989-65-8 结构式

基本信息

中文别名
2-[(2R,3R)-2-羟基-3-[(3-羟基-2-甲基苯甲酰)氨基]-4-(苯基硫)丁基]-(3S,4aS,8aS)-N-叔丁基十氢异喹啉-3-甲酰胺甲磺酸盐
甲磺酸奈非那韦
甲磺酸萘非那韦
奈非那维
英文别名
(3s,4as,8as)-n-(1,1-dimethylethyl)decahydro-2-[(2r,3r)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide mesylate
AG-1343
NELFINAVIR MESYLATE
8a-beta))-a-betmonomethanesulfonate(salt)
droxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-,(3s-(2(2,s*,3s*),3-alpha,4
viracept
Nelfinavir1
(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide
NELFINAVIRMESYLATE(SUBJECTTOPATENTFREE)
Nelfinavir nesylate
(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide mesylate
(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-N-tert-butyl-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
所属类别
生物化工:HIV Protease 抑制剂

物理化学性质

熔点131-135°C
储存条件Keep in dark place,Inert atmosphere,2-8°C
溶解度二甲基亚砜:≥2mg/mL
酸度系数(pKa)pKa -1.20(at 25℃)
形态粉末
颜色白色至灰白色
水溶解性4.5g/L(temperature not stated)
Merck14,6443
BCS Class2,4
稳定性DMSO中的溶液可在-20°下稳定储存3个月。
InChIKeyNQHXCOAXSHGTIA-SKXNDZRYSA-N

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H413
防范说明P501-P273
WGK Germany3
RTECS号NW6995333
海关编码29334900

应用领域

用途一
用作抗病毒药
甲磺酸奈非那韦价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/04/30HY-15287A甲磺酸奈非那韦
Nelfinavir Mesylate
159989-65-85mg600元
2024/04/30N0986甲磺酸奈非那韦 水合物
Nelfinavir Mesylate Hydrate
159989-65-825mg690元
2024/04/30HY-15287A甲磺酸奈非那韦
Nelfinavir Mesylate
159989-65-810mM * 1mLin DMSO880元

常见问题列表

生物活性
Nelfinavir Mesylate (Viracept, AG1343) 是强效的HIV protease抑制剂,Ki为2 nM。
靶点
TargetValue
HIV protease
(Cell-free assay)
2 nM(Ki)
体外研究

Nelfinavir (AG1341) Mesylate (1-10 μM; 48 hours) inhibits the proliferation of multiple myeloma cells.
Nelfinavir Mesylate inhibits 26S chymotrypsin-like proteasome activity, impairs proliferation and triggers apoptosis of the myeloma cell lines and fresh plasma cells.
Nelfinavir Mesylate (1-10 μM; 17 hours) induces apoptosis of multiple myeloma cell lines.
Nelfinavir Mesylate (5 μM; 0-24 hours) decreases the phosphorylation of AKT.
Nelfinavir Mesylate activates the cleavage of caspase-3, decreases the phosphorylation of AKT, STAT-3, ERK1/2, and activates the pro-apoptotic pathway of the unfolded protein response system.

Cell Proliferation Assay

Cell Line: RPMI, LP1, U266, OPM2 and MM1S cells
Concentration: 1, 2, 5, 10 μM
Incubation Time: 48 hours
Result: Inhibited the proliferation of RPMI, LP1, U266, OPM2 and MM1S cell lines in a dose-dependent manner with an IC 50 of 1-5 μM.

Apoptosis Analysis

Cell Line: LP1 and U266 cells
Concentration: 1-10 μM
Incubation Time: 17 hours
Result: Induced a dose-dependent increase in the percentage of annexin V + /propidium iodide + cells.

Western Blot Analysis

Cell Line: U266 cells
Concentration: 5 μM
Incubation Time: 0-24 hours
Result: The level of AKT phosphorylation in U266 cells decreased.
体内研究
体内研究表明AG1343在多个物种口服后能很好地被吸收,在人类中具有良好的药代动力学特征。在饲养大鼠中,该化合物的口服生物利用度为43%,而在禁食大鼠中,口服生物利用度显著下降至29%。在多种生物体内,Nelfinavir的生物口服利用度为:犬类中47%、狨猴中17%、食蟹猴中26%。在口服后,其在血浆中半衰期较长,这可能是因为分解和吸收较慢的缘故。在人类中,Nelfinavir能很好地被吸收,尤其是随食物给药时,具有比较少、容易处理的副作用,安全性良好。
"159989-65-8" 相关产品信息
1493-13-6 152459-95-5 128-37-0 163680-77-1 70458-95-6 58479-61-1 1634-04-4 75-75-2 1914-99-4 103-79-7 6329-61-9 159989-65-8